These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12665330)

  • 21. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
    Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
    J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocytochemical localization of estrogen and progesterone receptors (ER & PgR) in breast cancer.
    Fukushima H; Matsuda M; Kawakami H; Kudo A; Kuroki Y; Sakurai M; Shohji T; Nagashima Y; Asami M; Hanaoka T
    Okajimas Folia Anat Jpn; 1995 Mar; 71(6):365-70. PubMed ID: 7739846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study.
    Nishimura R; Murata Y; Mori K; Yamashiro K; Kuraoka K; Ichihara S; Taguchi K; Suzuki H; Ito M; Yamashita N
    Acta Cytol; 2018; 62(4):288-294. PubMed ID: 29763896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings.
    Stierer M; Rosen H; Weber R; Hanak H; Auerbach L; Spona J; Tüchler H
    Breast Cancer Res Treat; 1998 Jul; 50(2):125-34. PubMed ID: 9822217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
    Hicks D; Dell'Orto P; Falzon M; Hoff KD; Levy YY; McMahon L; Miller K; Russo L; Viale G
    Appl Immunohistochem Mol Morphol; 2017; 25(5):313-319. PubMed ID: 26657878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study on methodology and the criteria for positive immunohistostaining of estrogen and progesterone receptors in paraffin embedded sections of breast cancer].
    Lu X; Chen S; Huang S
    Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):329-31. PubMed ID: 9388856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.
    Kimambo AH; Vuhahula EA; Mwakigonja AR; Ljung BM; Zhang L; Van Loon K; Ng DL
    Arch Pathol Lab Med; 2021 Jul; 145(7):834-841. PubMed ID: 33053150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
    Layfield LJ; Saria EA; Conlon DH; Kerns BJ
    J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.
    Elledge RM; Ciocca DR; Langone G; McGuire WL
    Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
    Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
    Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
    Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
    Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different antibodies for detection of progesterone receptor in breast cancer.
    Press M; Spaulding B; Groshen S; Kaminsky D; Hagerty M; Sherman L; Christensen K; Edwards DP
    Steroids; 2002 Aug; 67(9):799-813. PubMed ID: 12123792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays.
    Chapman JW; Mobbs BG; McCready DR; Lickley HL; Trudeau ME; Hanna W; Kahn HJ; Sawka CA; Fish EB; Pritchard KI
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):323-8. PubMed ID: 8639468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group.
    Fernö M; Bendahl PO; Brisfors A; Byman K; Ekeberg M; Ferraud L; Grankvist K; Hjalmers B; Nilsson A; Sellberg G; Skoog L; Stål O; Wingmo I
    Acta Oncol; 1997; 36(8):793-8. PubMed ID: 9482684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222.
    Miller RT; Hapke MR; Greene GL
    Cancer; 1993 Jun; 71(11):3541-6. PubMed ID: 8490902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.